Volume 21 Issue 7
Jul.  2023
Turn off MathJax
Article Contents
HUANG Ting, GONG Huiyuan, TANG Zhen, LI Wei, ZHANG Lei, LI Xiaojun, GAO Xiong. Expression of KLHL7 in non-small cell lung cancer and its clinical significance[J]. Chinese Journal of General Practice, 2023, 21(7): 1109-1112. doi: 10.16766/j.cnki.issn.1674-4152.003061
Citation: HUANG Ting, GONG Huiyuan, TANG Zhen, LI Wei, ZHANG Lei, LI Xiaojun, GAO Xiong. Expression of KLHL7 in non-small cell lung cancer and its clinical significance[J]. Chinese Journal of General Practice, 2023, 21(7): 1109-1112. doi: 10.16766/j.cnki.issn.1674-4152.003061

Expression of KLHL7 in non-small cell lung cancer and its clinical significance

doi: 10.16766/j.cnki.issn.1674-4152.003061
Funds:

 KJ2020A0575

 2020b07030008

  • Received Date: 2022-08-28
    Available Online: 2023-08-28
  •   Objective  To investigate the correlation between the expression of Kelch-like family member 7 (KLHL7) in non-small cell lung cancer (NSCLC) tissue and paracancerous tissue and the prognosis of NSCLC patients.  Methods  The difference of KLHL7 expression in NSCLC tissue and paracancerous tissue was analyzed by using TIMER and UALCAN database respectively. The Kaplan-Meier plotter website was used to analyze the effects of KLHL7 expression levels on the prognosis of patients with NSCLC. A total of 96 patients with NSCLC who received surgical treatment in the First Affiliated Hospital of Bengbu Medical College from January 2014 to December 2016 were selected. Immunohistochemistry was used to detect the expression levels of KLHL7 in NSCLC tissue and paracancerous tissue.  Results  Bioinformatics analysis found that the expression of KLHL7 in NSCLC tissue was significantly increased and the prognosis was poor. Immunohistochemistry staining showed that the positive rate of KLHL7 protein expression in NSCLC tissue was significantly higher than that in paracancerous tissue (57.3% vs. 3.1%, P < 0.001). High KLHL7 expression was significantly correlated with diameter of tumor >3 cm, low tumor cell differentiation, lymph node metastasis and high TNM stage (all P < 0.05). The results of K-M survival analysis showed that tumor diameter, tumor cell differentiation, lymph node metastasis, TNM stage and KLHL7 expression level were all prognostic factors of NSCLC patients (all P < 0.05). Multivariate analysis showed that low tumor cell differentiation, lymph node metastasis, high TNM stage and high KLHL7 expression were independent risk factors affecting postoperative survival time of NSCLC patients (all P < 0.05).  Conclusion  KLHL7 is highly expressed in NSCLC tissue and correlated with tumor progression, which is an independent risk factor affecting prognosis of patients with NSCLC and has certain clinical value for prognosis assessment.

     

  • loading
  • [1]
    SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72(1): 7-33. doi: 10.3322/caac.21708
    [2]
    LI M, MENG G X, LIU X W, et al. Deep-LC: a novel deep learning method of identifying non-small cell lung cancer-related genes[J]. Front Oncol, 2022, 12: 949546. DOI: 10.3389/fonc.2022.949546.
    [3]
    GUO H Y, ZHANG J, QIN C, et al. Biomarker-targeted therapies in non-small cell lung cancer: current status and perspectives[J]. Cells, 2022, 11(20): 3200-3224. doi: 10.3390/cells11203200
    [4]
    刘彩霞, 贾金虎, 井丽君, 等. 新靶位基因RET在非小细胞肺癌中的研究进展[J]. 中国医药, 2019, 14(4): 618-620. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG201904035.htm

    LIU C X, JIA J H, JING L J, et al. Research progress of new target gene RET in non-small cell lung cancer[J]. China Medicine, 2019, 14(4): 618-620. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG201904035.htm
    [5]
    SUN T S, LIU Z N, YANG Q. The role of ubiquitination and deubiquitination in cancer metabolism[J]. Mol Cancer, 2020, 19(1): 146. doi: 10.1186/s12943-020-01262-x
    [6]
    DENG L, MENG T, CHEN L, et al. The role of ubiquitination in tumorigenesis and targeted drug discovery[J]. Signal Transduct Target Ther, 2020, 5(1): 11-39. doi: 10.1038/s41392-020-0107-0
    [7]
    GUO J H, ZHAO J, FU W, et al. Immune evasion and drug resistance mediated by USP22 in cancer: novel targets and mechanisms[J]. Front Immunol, 2022, 13: 918314. DOI: 10.3389/fimmu.2022.918314.
    [8]
    ANGIUS A, UVA P, BUERS I, et al. Bi-allelic mutations in KLHL7 cause a crisponi/CISS1-like phenotype associated with early-onset retinitis pigmentosa[J]. Am J Hum Genet, 2018, 102(4): 713-722.
    [9]
    WANG P, SONG J B, YE D. CRL3s: the BTB-CUL3-RING E3 ubiquitin ligases[J]. Adv Exp Med Biol, 2020, 1217: 211-223.
    [10]
    KUROZUMI S, JOSEPH C, SONBUL S, et al. Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis[J]. Breast Cancer Res Treat, 2018, 170(3): 525-533. doi: 10.1007/s10549-018-4777-z
    [11]
    XIA C F, DONG X S, LI H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135(5): 584-590. doi: 10.1097/CM9.0000000000002108
    [12]
    WEI C H, DONG X M, LU H, et al. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway[J]. J Exp Clin Cancer Res, 2019, 38(1): 95-111. doi: 10.1186/s13046-019-1092-4
    [13]
    郭莹, 高天慧, 赵孟阳, 等. 晚期非小细胞肺癌淋巴细胞亚群及细胞因子与免疫疗效的关系研究[J]. 中华全科医学, 2022, 20(9): 1462-1465. doi: 10.16766/j.cnki.issn.1674-4152.002623

    GUO Y, GAO T H, ZHAO M Y, et al. Study on the relationship between lymphocyte subsets, cytokines and immune efficacy in advanced non-small cell lung cancer[J]. Chinese Journal of General Practice, 2022, 20(9): 1462-1465. doi: 10.16766/j.cnki.issn.1674-4152.002623
    [14]
    RIUDAVETS M, SULLIVAN I, ABDAYEM P, et al. Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations[J]. ESMO Open, 2021, 6(5): 100260. DOI: 10.1016/j.esmoop.2021.100260.
    [15]
    WANG M N, HERBST R S, BOSHOFF C. Toward personalized treatment approaches for non-small-cell lung cancer[J]. Nat Med, 2021, 27(8): 1345-1356. doi: 10.1038/s41591-021-01450-2
    [16]
    CHOI J, LEE K, INGVARSDOTTIR K, et al. Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2[J]. Nat Cell Biol, 2018, 20(5): 586-596. doi: 10.1038/s41556-018-0084-5
    [17]
    YE G H, WANG J, YANG W L, et al. The roles of KLHL family members in human cancers[J]. Am J Cancer Res, 2022, 12(11): 5105-5139.
    [18]
    MORAIS-RODRIGUES F, SILV E R, KATO R B, et al. Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression[J]. Gene, 2020, 726: 144168. DOI: 10.1016/j.gene.2019.144168.
    [19]
    HAN M, YANG H J, LIN Q. KLHL14, an ovarian and endometrial-specific gene, is over-expressed in ovarian and endometrial cancer[J]. Math Biosci Eng, 2019, 17(2): 1702-1717.
    [20]
    KUROZUMI S, JOSEPH C, SONBUL S, et al. Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis[J]. Breast Cancer Res Treat, 2018, 170(3): 525-533. doi: 10.1007/s10549-018-4777-z
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(3)

    Article Metrics

    Article views (223) PDF downloads(14) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return